Heart Beat March 2007 Issue

Heart Beat: 03/07

Patients fitted with drug-coated stents are advised to stay on anti-clotting drugs for at least a year. The advisory recommends doctors tell their patients to take an anti-clotting drug such as clopidogrel and aspirin for a year to reduce the risk of clotting, which could lead to a heart attack or death. The long-term safety of clopidogrel bisulfate (Plavix) in stent patients has not been established.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.